Ad is loading...
RAGHX
Price
$28.12
Change
-$0.66 (-2.29%)
Updated
Nov 15 closing price
VGHCX
Price
$204.50
Change
-$5.96 (-2.83%)
Updated
Nov 15 closing price
Ad is loading...

RAGHX vs VGHCX

Header iconRAGHX vs VGHCX Comparison
Open Charts RAGHX vs VGHCXBanner chart's image
Virtus KAR Health Sciences A
Price$28.12
Change-$0.66 (-2.29%)
VolumeN/A
CapitalizationN/A
Vanguard Health Care I
Price$204.50
Change-$5.96 (-2.83%)
VolumeN/A
CapitalizationN/A
RAGHX vs VGHCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RAGHX vs. VGHCX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RAGHX is a Sell and VGHCX is a Sell.

FUNDAMENTALS
Fundamentals
VGHCX has more cash in the bank: 45.7B vs. RAGHX (127M). VGHCX pays higher dividends than RAGHX: VGHCX (0.79) vs RAGHX (0.00). RAGHX was incepted earlier than VGHCX: RAGHX (23 years) vs VGHCX (41 years). RAGHX is a more actively managed with annual turnover of: 75.00 vs. VGHCX (16.00). RAGHX has a lower initial minimum investment than VGHCX: RAGHX (2500) vs VGHCX (3000). RAGHX annual gain was more profitable for investors over the last year : 8.20 vs. VGHCX (1.65). VGHCX return over 5 years is better than : -2.73 vs. RAGHX (-16.77).
RAGHXVGHCXRAGHX / VGHCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years41 years-
Gain YTD-0.741-2.20534%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets127M45.7B0%
Annual Yield % from dividends0.000.79-
Returns for 1 year8.201.65498%
Returns for 3 years-30.72-13.85222%
Returns for 5 years-16.77-2.73615%
Returns for 10 years-24.27-9.94244%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UDR44.31-0.24
-0.54%
UDR
EXTO3.91-0.02
-0.57%
Almacenes Exito SA
OI12.97-0.17
-1.29%
O-I Glass
VIRX0.15-0.01
-4.37%
Viracta Therapeutics
PEPG4.12-0.37
-8.24%
PepGen